Novartis calls for more research into rare diseases
28 February 2014
In recognition of Rare Disease Day Novartis has called for a
global exchange of ideas to improve the understanding of rare
diseases and help address a significant unmet medical need.
Rare Disease Day is an annual, international awareness-raising
event coordinated globally by EURORDIS and in the US by the National
Organization for Rare Disorders (NORD). The main objective is to
raise awareness amongst the general public and decision-makers about
rare diseases and their impact on patients' lives.
While these diseases may be rare, their impact is great. There
are more than 6,000 rare diseases affecting more than 60 million
people across Europe and North America and millions more worldwide.
"Novartis is pleased to help raise the dialogue about rare
diseases and the need for more research to understand these diseases
better," said Dr. Mark Fishman, President of the Novartis Institutes
for BioMedical Research (NIBR). "Our focus on rare diseases flows
from our desire to help patients underserved by today's medicines.
In addition, research into rare diseases teaches us fundamental
mechanisms of human biology and disease, often applicable to more
Novartis is sponsoring and hosting the RE(ACT) Congress 2014, the
second international conference on research of rare and orphan
diseases, organized by the Gebert Rüf Foundation and the
Blackswan Foundation .
"We continue to look for new ways to combine our own scientific
knowledge and expertise with that of the rest of the research
community, to find the shortest path to new treatments for rare
diseases," said Dr. Fishman.
1. The RE(ACT) Congress 2014 will be held on the Novartis Basel
Campus from March 5th to 8th, 2014 will provide the global research
community with a platform to connect, exchange ideas and deepen
fundamental understanding of rare diseases.
For more information visit